Rifamycin SV | CAS#15105-92-7

MedKoo Cat#: 525314 | Name: Rifamycin SV sodium salt

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Rifamycin SV is a natural antibiotic, inhibiting prokaryotic DNA-dependent RNA synthesis and protein synthesis; blocking RNA-polymerase transcription initiation, modulating ß2m aggregation.

Chemical Structure

Rifamycin SV sodium salt

CAS#15105-92-7 (sodium)

Theoretical Analysis

MedKoo Cat#: 525314

Name: Rifamycin SV sodium salt

CAS#: 15105-92-7 (sodium)

Chemical Formula: C38H49NO11

Exact Mass: 695.3306

Molecular Weight: 695.81

Elemental Analysis: C, 65.60; H, 7.10; N, 2.01; O, 25.29

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

6998-60-3 (free acid) 15105-92-7 (sodium)

Synonym

Nsc133100, Rifamycin SV Na, Rifamycin sodium, Rifamycin Na, Rifomycin sodium salt, Rifomycin sodium, Rifomycin Na

IUPAC/Chemical Name

5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate

InChi Key

MRUNNYXNBAKPBP-YGYFUBKZSA-N

InChi Code

InChI=1S/C38H49NO11/c1-17-12-10-13-18(2)37(47)39-24-16-25(41)27-28(33(24)45)32(44)22(6)35-29(27)36(46)38(8,50-35)15-11-14-26(48-9)19(3)34(49-23(7)40)21(5)31(43)20(4)30(17)42/h10-14,16-17,19-21,26,30-31,34,41-45H,15H2,1-9H3,(H,39,47)/b12-10+,14-11+,18-13-/t17-,19+,20+,21+,26-,30-,31+,34+,38+/m0/s1

SMILES Code

OC1=C(NC(/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/C[C@@]2(C)O3)=O)C=C(O)C4=C1C(O)=C(C)C3=C4C2=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 695.81 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Marcinko TM, Dong J, LeBlanc R, Daborowski KV, Vachet RW. Small Molecule-mediated Inhibition of β-2-Microglobulin Amyloid Fibril Formation. J Biol Chem. 2017 May 3. pii: jbc.M116.774083. doi: 10.1074/jbc.M116.774083. [Epub ahead of print] PubMed PMID: 28468825. 2: Kimoto E, Bi YA, Kosa RE, Tremaine LM, Varma MVS. Hepatobiliary Clearance Prediction: Species Scaling from Monkey, Dog and Rat, and In Vitro-In Vivo Extrapolation of Sandwich Cultured Human Hepatocytes using 17 Drugs. J Pharm Sci. 2017 Apr 26. pii: S0022-3549(17)30279-4. doi: 10.1016/j.xphs.2017.04.043. [Epub ahead of print] PubMed PMID: 28456723. 3: Narang SS, Shuaib S, Goyal B. Molecular insights into the inhibitory mechanism of rifamycin SV against β(2)-microglobulin aggregation: A molecular dynamics simulation study. Int J Biol Macromol. 2017 Apr 25;102:1025-1034. doi: 10.1016/j.ijbiomac.2017.04.086. [Epub ahead of print] PubMed PMID: 28455257. 4: Bond TEH, Sorenson AE, Schaeffer PM. Functional characterisation of Burkholderia pseudomallei biotin protein ligase: A toolkit for anti-melioidosis drug development. Microbiol Res. 2017 Jun;199:40-48. doi: 10.1016/j.micres.2017.03.007. Epub 2017 Mar 19. PubMed PMID: 28454708. 5: Thompson JM, Saini V, Ashbaugh AG, Miller RJ, Ordonez AA, Ortines RV, Wang Y, Sterling RS, Jain SK, Miller LS. Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model. J Bone Joint Surg Am. 2017 Apr 19;99(8):656-665. doi: 10.2106/JBJS.16.01002. PubMed PMID: 28419033. 6: Meaza A, Kebede A, Yaregal Z, Dagne Z, Moga S, Yenew B, Diriba G, Molalign H, Tadesse M, Adisse D, Getahun M, Desta K. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. BMC Infect Dis. 2017 Apr 17;17(1):280. doi: 10.1186/s12879-017-2389-6. PubMed PMID: 28415989; PubMed Central PMCID: PMC5392973. 7: Haley CA. Treatment of Latent Tuberculosis Infection. Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0039-2016. Review. PubMed PMID: 28409555. 8: Leonard MK, Blumberg HM. Musculoskeletal Tuberculosis. Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0046-2017. Review. PubMed PMID: 28409551. 9: Park GJ, Bae SH, Park WS, Han S, Park MH, Shin SH, Shin YG, Yim DS. Drug-drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer. Drug Des Devel Ther. 2017 Mar 30;11:1043-1053. doi: 10.2147/DDDT.S131797. eCollection 2017. PubMed PMID: 28408803; PubMed Central PMCID: PMC5384691. 10: Zimmerli W, Sendi P. Orthopaedic biofilm infections. APMIS. 2017 Apr;125(4):353-364. doi: 10.1111/apm.12687. Review. PubMed PMID: 28407423. 11: Holzschuh EL, Province S, Johnson K, Walls C, Shemwell C, Martin G, Showalter A, Dunlay J, Conyers A, Griffin P, Tausz N. Use of Video Directly Observed Therapy for Treatment of Latent Tuberculosis Infection - Johnson County, Kansas, 2015. MMWR Morb Mortal Wkly Rep. 2017 Apr 14;66(14):387-389. doi: 10.15585/mmwr.mm6614a3. PubMed PMID: 28406884. 12: Freyne B, Curtis N. Mycobacterium gordonae Skin Infection in an Immunocompetent Child. Pediatr Infect Dis J. 2017 May;36(5):523-525. doi: 10.1097/INF.0000000000001549. PubMed PMID: 28403059. 13: Rabie H, Decloedt EH, Garcia-Prats AJ, Cotton MF, Frigati L, Lallemant M, Hesseling A, Schaaf HS. Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis. Expert Opin Pharmacother. 2017 Apr;18(6):589-598. doi: 10.1080/14656566.2017.1309023. Epub 2017 Mar 27. Review. PubMed PMID: 28346018. 14: Gokarn K, Pal RB. Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test. BMC Complement Altern Med. 2017 Mar 21;17(1):161. doi: 10.1186/s12906-017-1665-8. PubMed PMID: 28327117; PubMed Central PMCID: PMC5361708. 15: Shrivastava N, Set R, Bankar S, Shastri J. Detection of ofloxacin resistance by nitrate reductase assay in Mycobacterium tuberculosis isolates from extrapulmonary tuberculosis. Indian J Med Microbiol. 2017 Jan-Mar;35(1):69-73. doi: 10.4103/ijmm.IJMM_16_266. PubMed PMID: 28303821. 16: Bouazzi OE, Hammi S, Bourkadi JE, Tebaa A, Tanani DS, Soulaymani-Bencheikh R, Badrane N, Bengueddour R. First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors. Pan Afr Med J. 2016 Nov 16;25:167. doi: 10.11604/pamj.2016.25.167.10060. eCollection 2016. PubMed PMID: 28292129; PubMed Central PMCID: PMC5326068. 17: Diallo AB, Kollo AI, Camara M, Lo S, Ossoga GW, Mbow M, Karam F, Niang MY, Thiam A, Diawara AN, Mboup S, Diallo AG. [Performance of GeneXpert MTB / RIF(®) in the diagnosis of extrapulmonary tuberculosis in Dakar: 2010-2015]. Pan Afr Med J. 2016 Nov 2;25:129. doi: 10.11604/pamj.2016.25.129.10065. eCollection 2016. French. PubMed PMID: 28292091; PubMed Central PMCID: PMC5325514. 18: Moon SM, Jhun BW, Lee H, Park HY, Jeon K, Lee SY, Koh WJ. Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease. J Infect Chemother. 2017 Mar 8. pii: S1341-321X(17)30031-4. doi: 10.1016/j.jiac.2017.02.004. [Epub ahead of print] PubMed PMID: 28284662. 19: Nowakiewicz A, Ziółkowska G, Trościańczyk A, Zięba P, Gnat S. Determination of antimicrobial resistance of Enterococcus strains isolated from pigs and their genotypic characterization by method of amplification of DNA fragments surrounding rare restriction sites (ADSRRS fingerprinting). J Med Microbiol. 2017 Mar;66(2):175-183. doi: 10.1099/jmm.0.000400. PubMed PMID: 28260584. 20: Demir E, Sever MS. Posttransplant Tuberculosis. Exp Clin Transplant. 2017 Feb;15(Suppl 1):10-15. PubMed PMID: 28260424.